List of Tables
Table 1. Gene Therapy on Cancer Market Trends
Table 2. Gene Therapy on Cancer Market Drivers & Opportunity
Table 3. Gene Therapy on Cancer Market Challenges
Table 4. Gene Therapy on Cancer Market Restraints
Table 5. Global Gene Therapy on Cancer Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gene Therapy on Cancer Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gene Therapy on Cancer Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gene Therapy on Cancer Product Type
Table 9. Key Companies Time to Begin Mass Production of Gene Therapy on Cancer
Table 10. Global Gene Therapy on Cancer Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Cancer as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gene Therapy on Cancer Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gene Therapy on Cancer Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gene Therapy on Cancer Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gene Therapy on Cancer Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gene Therapy on Cancer Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gene Therapy on Cancer Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gene Therapy on Cancer Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gene Therapy on Cancer Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gene Therapy on Cancer Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gene Therapy on Cancer Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gene Therapy on Cancer Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gene Therapy on Cancer Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gene Therapy on Cancer Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gene Therapy on Cancer Sales Value by Region (2019-2024) & (%)
Table 27. Global Gene Therapy on Cancer Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gene Therapy on Cancer Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gene Therapy on Cancer Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gene Therapy on Cancer Sales Value, (2025-2030) & (US$ Million)
Table 31. Novartis Basic Information List
Table 32. Novartis Description and Business Overview
Table 33. Novartis Gene Therapy on Cancer Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gene Therapy on Cancer Business of Novartis (2019-2024)
Table 35. Novartis Recent Developments
Table 36. Gilead Sciences Basic Information List
Table 37. Gilead Sciences Description and Business Overview
Table 38. Gilead Sciences Gene Therapy on Cancer Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gene Therapy on Cancer Business of Gilead Sciences (2019-2024)
Table 40. Gilead Sciences Recent Developments
Table 41. Amgen Basic Information List
Table 42. Amgen Description and Business Overview
Table 43. Amgen Gene Therapy on Cancer Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gene Therapy on Cancer Business of Amgen (2019-2024)
Table 45. Amgen Recent Developments
Table 46. Shanghai Sunway Basic Information List
Table 47. Shanghai Sunway Description and Business Overview
Table 48. Shanghai Sunway Gene Therapy on Cancer Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gene Therapy on Cancer Business of Shanghai Sunway (2019-2024)
Table 50. Shanghai Sunway Recent Developments
Table 51. Sibiono Basic Information List
Table 52. Sibiono Description and Business Overview
Table 53. Sibiono Gene Therapy on Cancer Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gene Therapy on Cancer Business of Sibiono (2019-2024)
Table 55. Sibiono Recent Developments
Table 56. Key Raw Materials Lists
Table 57. Raw Materials Key Suppliers Lists
Table 58. Gene Therapy on Cancer Downstream Customers
Table 59. Gene Therapy on Cancer Distributors List
Table 60. Research Programs/Design for This Report
Table 61. Key Data Information from Secondary Sources
Table 62. Key Data Information from Primary Sources
Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gene Therapy on Cancer Product Picture
Figure 2. Global Gene Therapy on Cancer Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 4. Gene Therapy on Cancer Report Years Considered
Figure 5. Global Gene Therapy on Cancer Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Therapy on Cancer Revenue in 2023
Figure 7. Gene Therapy on Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Viral Gene Therapy Picture
Figure 9. Non-viral Gene Therapy Picture
Figure 10. Global Gene Therapy on Cancer Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Gene Therapy on Cancer Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Other
Figure 15. Global Gene Therapy on Cancer Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Gene Therapy on Cancer Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Gene Therapy on Cancer Sales Value (%), (2019-2030)
Figure 28. United States Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 34. China Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 36. China Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 46. India Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
Figure 48. India Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
Figure 49. Gene Therapy on Cancer Industrial Chain
Figure 50. Gene Therapy on Cancer Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation